Vivasure hope to find room in a competitive market with its surtureless implant that is absorbed 180 days after vessel ...

Novocure has obtained CE Mark approval for its Optune Lua device to treat adults with metastatic non-small cell lung cancer ...

Biolinq has secured $100m in Series C funds to support the regulatory approval process in the US to launch its intradermal ...

Semiconductors are used in half of all medical devices, with impending tariffs on their import likely to impact the US ...

Until recently, the choice of full-service outsourcing (FSO) vs functional service partnerships (FSP) most frequently was ...